Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Glioblastoma 1

Interventions

Temozolomide 31 Magnetic Resonance Spectroscopy 31 Specimen Handling 18 Radiation 13 Radiotherapy 12 Biopsy 11 Bevacizumab 11 Nivolumab 9 X-Rays 7 Radiosurgery 7 Nuclear Medicine Department, Hospital 7 Carboplatin 7 Lomustine 6 Cyclophosphamide 6 Vincristine 5 Phantoms, Imaging 5 Cisplatin 5 ulixertinib 4 trametinib 4 pembrolizumab 4 erdafitinib 4 binimetinib 4 abemaciclib 4 Irinotecan 4 Ipilimumab 4 Immunoglobulin G 4 Etoposide 4 Disulfides 4 Aminolevulinic Acid 4 AZD 6244 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Dianhydrogalactitol × CNS × 30 days × Clear all

NCT03970447 2026-06-03

GBM AGILE

Global Coalition for Adaptive Research

Phase 2/3 Recruiting

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡